Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06425900
PHASE4

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

Sponsor: Sun Pharmaceutical Industries Limited

View on ClinicalTrials.gov

Summary

to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment

Official title: Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%

Key Details

Gender

All

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2024-07-01

Completion Date

2026-03

Last Updated

2026-01-21

Healthy Volunteers

No

Conditions

Interventions

DRUG

Winlevi (Clascoterone) cream 1%

Dosed twice daily (BID)

Locations (1)

Dermatology Consulting Services, PLLC

High Point, North Carolina, United States